Literature DB >> 17699488

Relationships of plasma renin levels with renal function in patients with primary aldosteronism.

Cristiana Catena1, GianLuca Colussi, Elisa Nadalini, Alessandra Chiuch, Sara Baroselli, Roberta Lapenna, Leonardo A Sechi.   

Abstract

BACKGROUND: The renal damage that is present in primary aldosteronism might reflect functional and potentially reversible abnormalities that are initiated by glomerular hyperfiltration. The aim of this study was to investigate the relationships of plasma renin and aldosterone concentrations with renal outcomes after treatment of primary aldosteronism. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS: Fifty-six consecutive patients who had primary aldosteronism and were recruited in a university center were studied. Patients were prospectively followed after either surgical or medical treatment for a mean of 6.2 yr, during which they received antihypertensive drugs to reach a target BP of <140/90 mmHg.
RESULTS: At baseline, patients with primary aldosteronism had higher creatinine clearance and albuminuria than 323 patients with essential hypertension and 113 normotensive individuals. In patients with primary aldosteronism, plasma active renin levels that were higher than the lower limit of detection (2.5 pg/ml) were associated with higher BP, plasma potassium, and albuminuria and lower creatinine clearance. Plasma aldosterone concentrations that were higher than the median value (225 pg/ml) were associated with lower plasma potassium and higher creatinine clearance. Creatinine clearance was correlated directly with plasma aldosterone and inversely with renin. During follow-up, patients with higher baseline plasma renin required use of more antihypertensive drugs to obtain BP control and had a smaller early decline in albuminuria than did patients with suppressed renin.
CONCLUSIONS: Escape of renin from suppression by excess aldosterone is associated with evidence of more severe renal damage in patients with primary aldosteronism and predicts less favorable outcomes after treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17699488     DOI: 10.2215/CJN.00050107

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  24 in total

1.  Development of novel nomograms to predict renal functional outcomes after laparoscopic adrenalectomy in patients with primary aldosteronism.

Authors:  Takanobu Utsumi; Naoto Kamiya; Mayuko Kaga; Takumi Endo; Masashi Yano; Shuichi Kamijima; Koji Kawamura; Takashi Imamoto; Tomohiko Ichikawa; Hiroyoshi Suzuki
Journal:  World J Urol       Date:  2017-04-11       Impact factor: 4.226

2.  Change in kidney function after unilateral adrenalectomy in patients with primary aldosteronism: identification of risk factors for decreased kidney function.

Authors:  Il Young Kim; In Seong Park; Min Jeong Kim; Miyeun Han; Harin Rhee; Eun Young Seong; Dong Won Lee; Soo Bong Lee; Ihm Soo Kwak; Sang Heon Song; Hyun Chul Chung
Journal:  Int Urol Nephrol       Date:  2018-05-19       Impact factor: 2.370

3.  Despite limited specificity, computed tomography predicts lateralization and clinical outcome in primary aldosteronism.

Authors:  G A Kline; V C Dias; B So; A Harvey; J L Pasieka
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

4.  Hypertension Cure Following Laparoscopic Adrenalectomy for Hyperaldosteronism is not Universal: Trends Over Two Decades.

Authors:  Takeshi Namekawa; Takanobu Utsumi; Tomoaki Tanaka; Mayuko Kaga; Hidekazu Nagano; Takashi Kono; Koji Kawamura; Naoto Kamiya; Takashi Imamoto; Hiroyoshi Suzuki; Tomohiko Ichikawa
Journal:  World J Surg       Date:  2017-04       Impact factor: 3.352

5.  Editorial comment from Dr Nishikawa et al. to preoperative masked renal damage in japanese patients with primary aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy.

Authors:  Tetsuo Nishikawa; Masao Omura; Jun Saito; Yoko Matsuzawa; Tomoshige Kino
Journal:  Int J Urol       Date:  2012-12-11       Impact factor: 3.369

Review 6.  A case of primary aldosteronism revealed after renal transplantation.

Authors:  Ewout J Hoorn; Dennis A Hesselink; Marcia M Kho; Joke I Roodnat; Willem Weimar; Jan L van Saase; Anton H van den Meiracker; Robert Zietse
Journal:  Nat Rev Nephrol       Date:  2010-11-23       Impact factor: 28.314

7.  Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essential hypertension. Case-control study.

Authors:  María Fernández-Argüeso; Eider Pascual-Corrales; Nuria Bengoa Rojano; Ana García Cano; Lucía Jiménez Mendiguchía; Marta Araujo-Castro
Journal:  Endocrine       Date:  2021-04-02       Impact factor: 3.633

8.  Intrarenal hemodynamics in primary aldosteronism before and after treatment.

Authors:  Leonardo A Sechi; Alessandro Di Fabio; Massimo Bazzocchi; Alessandro Uzzau; Cristiana Catena
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

9.  Development of a novel nomogram to predict hypertension cure after laparoscopic adrenalectomy in patients with primary aldosteronism.

Authors:  Takanobu Utsumi; Naoto Kamiya; Takumi Endo; Masashi Yano; Shuichi Kamijima; Koji Kawamura; Takashi Imamoto; Yukio Naya; Tomohiko Ichikawa; Hiroyoshi Suzuki
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

10.  Effects of Treating Primary Aldosteronism on Renal Function.

Authors:  Bart J Kramers; Cornelis Kramers; Jacques W M Lenders; Jaap Deinum
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-09-23       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.